Individualizing aspirin therapy for prevention of cardiovascular events

JAMA. 1998 Dec 9;280(22):1949-50. doi: 10.1001/jama.280.22.1949.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / prevention & control*
  • Cerebral Hemorrhage / etiology*
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Risk

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin